MannKind Newsroom

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cigna (CI), Hims & Hers Health (HIMS) and MannKind (MNKD)

TipRanksNov 6 03:13 ET

Leerink Partners Initiates MannKind(MNKD.US) With Buy Rating, Announces Target Price $8

Moomoo NewsSep 9 18:31 ET

MannKind Price Target Announced at $8.00/Share by Leerink Partners

Dow JonesSep 9 08:56 ET

MannKind Analyst Ratings

BenzingaAug 28 09:03 ET

Oppenheimer Maintains MannKind(MNKD.US) With Buy Rating, Raises Target Price to $12

Moomoo NewsAug 28 08:33 ET

Oppenheimer Reaffirms Their Buy Rating on MannKind (MNKD)

TipRanksAug 28 08:22 ET

MannKind's Strong Q2 Performance and Promising Pipeline Merit a Buy Rating

TipRanksAug 9 06:04 ET

Analysts Offer Insights on Healthcare Companies: MannKind (MNKD), Envista Holdings (NVST) and Soleno Therapeutics (SLNO)

TipRanksAug 8 08:31 ET

MannKind (MNKD) Gets a Hold From RBC Capital

TipRanksAug 8 08:29 ET

MannKind Analyst Ratings

BenzingaJun 13 13:42 ET

Oppenheimer Remains a Buy on MannKind (MNKD)

TipRanksMay 10 08:00 ET

MannKind Buy Rating Affirmed by Analyst Thomas Smith on Strong Revenue Growth and Promising Clinical Developments

TipRanksMay 10 01:30 ET

MannKind Analyst Ratings

BenzingaMay 9 10:57 ET

Analysts Offer Insights on Healthcare Companies: LENZ Therapeutics (LENZ), MannKind (MNKD) and Aquestive Therapeutics (AQST)

TipRanksMay 9 06:51 ET

Analysts Offer Insights on Healthcare Companies: MannKind (MNKD), Vertex Pharmaceuticals (VRTX) and Korro Bio (KRRO)

TipRanksApr 8 22:35 ET

MannKind Analyst Ratings

BenzingaMar 15 10:52 ET

MannKind's Strong Q4 Financials and Therapeutic Portfolio Potential Merit a Buy Rating

TipRanksMar 1 01:06 ET

MannKind Corporation: Strong Growth and Clinical Advancements Prompt Buy Rating

TipRanksFeb 28 08:55 ET

MannKind (MNKD) Receives a New Rating From Cantor Fitzgerald

TipRanksFeb 28 08:35 ET

RBC Capital Sticks to Their Hold Rating for MannKind (MNKD)

TipRanksFeb 28 07:19 ET